Hedge Fund - Duquesne Capital
Recursion Pharmaceuticals Inc. (RXRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $11.14 |
| 2 | 2023 - Q4 (2023-12-31) | $8,941,000 | 0.26% | 906,767 | $7.13 |
| 3 | 2023 - Q3 (2023-09-30) | $6,937,000 | 0.24% | 906,767 | $9.98 |
| 4 | 2023 - Q2 (2023-06-30) | $10,353,000 | 0.36% | 1,385,950 | $7.00 |
| 5 | 2023 - Q1 (2023-03-31) | $9,259,000 | 0.4% | 1,385,950 | $7.93 |
| 6 | 2022 - Q4 (2022-12-31) | $10,685,675 | 0.52% | 1,385,950 | $9.81 |
| 7 | 2022 - Q3 (2022-09-30) | $14,747,000 | 0.83% | 1,385,950 | $10.13 |
| 8 | 2022 - Q2 (2022-06-30) | $2,228,000 | 0.16% | 273,650 | $6.69 |
| 9 | 2022 - Q1 (2022-03-31) | $1,959,000 | 0.08% | 273,650 | $10.63 |
| 10 | 2021 - Q4 (2021-12-31) | $4,453,000 | 0.16% | 259,941 | $18.82 |
| 11 | 2021 - Q3 (2021-09-30) | $5,981,000 | 0.19% | 259,941 | $28.34 |
The displayed share prices are average quarterly stock market prices.